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Purpose: Written and electronic medicine information are important for improving patient
knowledge and safe use of medicines. Written medicine information in Thailand is mostly in
the form of printed package inserts (PIs), designed for health professionals, with few
medicines having patient information leaflets (PILs). The aim of this study was to determine
practices, needs and expectations of Thai general public about written and electronic
medicine information and attitudes towards PILs.
Patients and Methods: Cross-sectional survey, using self-completed questionnaires, was
distributed directly to members of the general public in a large city, during January to March
2019. It explored experiences of using information, expectations, needs and attitudes, the
latter measured using a 10-item scale. Differences between sub-groups were assessed,
applying the Bonferroni correction to determine statistical significance.
Results: Of the total 851 questionnaires distributed, 550 were returned (64.2%). The majority of
respondents (88%) had received PIs, but only a quarter (26.2%) had received PILs. Most
respondents (78.5%) had seen medicine information in online form. High educational level
and income increased the likelihood of receiving PILs and electronic information. The majority
of respondents (88.5%) perceived PILs as useful, but 70% considered they would still need
information about medicines from health professionals. Indication, drug name and precautions
were the most frequently read information in PIs and perceived as needed in PILs. Three-quarters
of respondents would read electronic information if it were available, with more who had
received a PIL having previously searched for such information compared to those who had
not. All respondents had positive overall attitudes towards PILs.
Conclusion: Experiences of receiving PILs and electronic medicine information in Thailand
are relatively limited. However, the general public considered PILs as a useful source of
medicine information. Electronic medicine information was desired and should be developed
to be an additional source of information for consumers.
Keywords: medicine information, general public, practices, attitudes, need and expectations
Introduction
Patients using medicines need information to enable them to maximize their safe and
effective use.1 Information about both potential benefits and risks of medicines can
improve patient knowledge and adherence.2–4 Presenting risk information to patients
can also have an effect on their decisions about taking medicines,5 increasingly
important for shared decision-making. In order to support this, patients require com-
prehensible information about side effects, interactions, precautions and benefits.1,6
However, studies in many countries have found that both patients and the
general public have low level of knowledge and awareness about the risks of
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medicines they use.6,7 There may be several reasons for
this limited knowledge. Some studies found limited provi-
sion of medicine information by health professionals
(HPs) due to their concerns about its impact on the doc-
tor–patient relationship, a lack of time for providing infor-
mation, and complexity of the information.8 In addition,
concerns have been expressed that providing such infor-
mation may reduce adherence.9 A further key factor is the
availability of suitable written information designed for
patient use.
Written medicine information (WMI) for patients may
be available in various forms such as patient information
leaflets (PILs), medication factsheets, brochures, and
booklets. WMI is effective in improving awareness,
knowledge,10–12 recall of medicine information,13 beha-
viors related to medicine taking including both adherence
and seeking other sources of medicine information.14
WMI may be provided routinely with medicines in the
form of PILs or package inserts (PIs). More recently,
online information about medicines has become a further
major source of information used by patients especially on
adverse effects, how to use the medicines, and drug
interactions.15 Internet sources however vary in the relia-
bility of information provided; hence, websites supported
by local and national health authorities are an important
source of trustworthy information. Multimedia education
can improve patient knowledge about medication and skill
acquisition.16
In Thailand, surveys have shown that HPs are major
sources of medicine information, with written information
being used less frequently. One key reason for this is the
lack of availability of PILs.17 More recently, a survey of
outpatients in Thailand found that almost all had seen a PI,
but few had ever received a PIL.18 PIs are essentially the
summary of product characteristics required by regulators
designed to provide up-to-date information to health pro-
fessionals. Regulations in many countries, including
Thailand, require these to be enclosed in packages of
every medicinal products.19 However, there are potentially
problems associated with patients’ ability to comprehend
the information in the PIs due to the technical language
used, small font, thin paper, too dense texts, and unattrac-
tive design.20 In addition, many studies have found that
some of these leaflets have incomplete information about
drug safety.17,21,22 The PIL is written in simple language
using a patient-friendly format to ensure patients’ under-
standing. These must be provided with every medicine in
European countries, instead of a PI. However, in Thailand,
PILs are only voluntarily provided by pharmaceutical
companies and few are distributed.
Attitudes of Thai patients towards receiving WMI are
positive,9 they report reading any form of WMI and per-
ceive PILs to be important.18 A previous survey of the
general public in Thailand conducted in 2014 found that,
although health professionals were the most desirable
sources of information, information leaflets were wanted
by almost 50%.23 However, no work has determined the
use of and attitudes towards such leaflets in the Thai
general public, nor has any research into the use or desire
for electronic medicine information been carried out in this
population. This study therefore aimed to determine
experiences, needs and expectations of written medicine
information and attitudes towards PILs among the Thai
general public.
Patients and Methods
Study Design and Setting
A cross-sectional study was conducted in Khon Kaen
province, Thailand, during 5 January to 31 March 2019.
Participants
Eligible participants were aged 18 years and over, and
were living in Mueang District, Khon Kaen province. All
provided verbal informed consent to take part in the study.
Sample size was calculated using Yamane’s equation with
5% margin of error, based on the 2017 census of inhabi-
tants domiciled in Mueang District, Khon Kaen province,
a previous study of the general public which achieved a
77% valid response rate,18 and the rate of refusal to parti-
cipate in a previous study which was 5.83%.24 The total
number of participants required was 550.
Questionnaire Development
A questionnaire for self-administration was developed by
the research team using a previous study regarding expec-
tation and needs of Thai patients towards PILs.18 The
questionnaire consisted of four sections as follows:
1. Demographic characteristics including age, gender,
education level, and income
2. Reading and use of written and electronic medicine
information
3. Needs and expectations of written and online med-
icine information
Wongtaweepkij et al Dovepress
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4. Attitudes towards PILs consisted of 10 statements,
using 5-point Likert-type Scale with responses ran-
ging from strongly disagree (1) to strongly agree (5).
Questionnaire Testing
The questionnaire was validated by three experts (one hos-
pital pharmacist, two clinical pharmacists) using index of
item objective congruence (IOC) technique. All questions
passed the content validity with IOC >0.5 of each item. All
three experts were also asked to assess the questionnaire
language and flow for ease of understanding. The question-
naire was then administered to15 people recruited from
non-academic staff of the University. All were asked to
complete the questionnaire and they were then asked to
comment on each question individually, in terms of ease
of understanding. The final questionnaire required only
very minor modifications following recommendations
from pilot and validation test.
Questionnaire Distribution
The final version of questionnaire was directly distributed
to potential participants using convenience sampling at six
types of public areas: university campus, public parks,
temples, markets, bus station and community centers
located in Khon Kaen province, Thailand. To ensure con-
sistency throughout this process, the questionnaire was
distributed and returned by one researcher. The researcher
provided assistance by reading the questionnaire to
respondents having visual problems but without providing
further explanation. The differences between PILs and PIs
were however explained to all participants to facilitate
them in differentiating between these types of written
medicine information.
Data Analysis
All questionnaire responses were entered into and the data
analyzed using SPSS for Windows version 19.0. Simple
frequencies were used to report demographic data, prac-
tices regarding written and electronic medicine informa-
tion, needs and expectations of written and online
medicine information. Attitude scores were calculated by
first reverse scoring responses to negative questions and
summing scores, then these were classified into three equal
categories; low (10–22 points), moderate (23–36 points)
and good attitude (37–50 points) based on previous
studies.25 Mean and standard deviations of each attitude
statement were also calculated. Internal consistency of the
attitude scale was tested using Cronbach’s α coefficient.
Pearson chi-square and Fisher’s exact test were used to
compare demographic characteristics of respondents who
had and had not ever read PIs, and those who had or had
not ever seen electronic medicine information. P-value less
than 0.05 with Bonferroni adjustment was accepted as
indicating significant differences between sub-groups.
Ethical Approval
The study was approved by the Khon Kaen University
Ethics Committee for Human Research (Number
HE611500) which approved the process of obtaining ver-
bal informed consent. All data were kept securely stored




A total of 851 questionnaires were distributed, of which
550 were fully completed and analyzed (response rate
64.2%). Reasons given for refusal to participate in the
study were: not convenient (n=225, 26.4%), not living in
Mueang district, Khon Kaen (n=46, 5.4%) and not speci-
fied (n=30, 3.5%. No further data were gathered from non-
responders).
Demographic Data
The majority of respondents were female (n=404, 73.5%)
and half were aged 18–44 years (Table 1). Almost two-
fifths of respondents had Bachelor’s degree and higher
education (n=214, 38.9%) and just over half had income
more than 10,000 baht per month (n=304, 55.3%).
Use of Written and Electronic Medicine
Information
Of the total 550 respondents, 484 (88.0%) had received
PIs, but only 144 (26.2%) had received PILs. The majority
of respondents (296, 61.1%) indicated that they always
read any medicine leaflets they received and 335 (81.1%)
read the leaflets at the first time of receiving the medicine.
We found significant differences in educational level,
income, and frequency of reading leaflets between those
who had and never received PILs (p<0.001). The respon-
dents who had received PILs had higher educational level
and income compared to those who had not. The propor-
tion of respondents who always read leaflets was higher
among those who had received PILs than those who had
not, whereas all respondents who never read any leaflets
Dovepress Wongtaweepkij et al
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about their medicines (n=71, 12.9% of total respondents)
had never received a PIL. As was found with PILs, we
also found significant differences in educational level and
income between respondents who had used electronic
information compared to those who had never used it
(p<0.001) (Table 1).
Table 1 Demographic Characteristics and Practices of Respondents in Relation to Experiences of PILs and Online Medicine
Information
Characteristics and Practices Total
(n=550)



















● Male 146 (26.5) 31 (21.5) 115 (28.3) 0.112 110 (25.5) 36 (30.5) 0.271
● Female 404 (73.5) 113 (78.5) 291 (71.7) 322 (74.5) 82 (69.5)
Age (years) (n=550, 100%)
● 18–44 285 (51.8) 82 (56.9) 203 (50.0) 0.348 233 (53.9) 52 (44.1) 0.016
● 45–60 176 (32.0) 42 (29.2) 134 (33.0) 139 (32.2) 37 (31.4)
● >60 89 (16.2) 20 (13.9) 69 (17.0) 60 (13.9) 29 (24.6)
Education level (n=550, 100%)
● Junior high school and lower 164 (29.8) 23 (16.0) 141 (34.7) <0.001 104 (24.1) 60 (50.8) <0.001
● Senior high school and diploma 172 (31.3) 36 (25.0) 136 (33.5) 138 (31.9) 34 (28.8)
● Bachelor’s degree and higher 214 (38.9) 85 (59.0) 129 (31.8) 190 (44.0) 24 (20.3)
Income per month (n=550, 100%)
● ≤10,000 baht 246 (44.7) 34 (23.6) 212 (52.2) <0.001 172 (39.8) 74 (62.7) <0.001
● >10,000 baht 304 (55.3) 110 (76.4) 194 (47.8) 260 (60.2) 44 (37.3)
Frequency of reading any medicine
leaflet (n=484, 88.0%)
● Always 296 (61.1) 114 (56.7) 182 (64.3) <0.001 244 (61.6) 52 (59.1) 0.376
● Sometimes 117 (24.2) 87 (43.3) 30 (10.6) 98 (24.8) 19 (21.6)
● Neverb 71 (14.7) 0 (0.0) 71 (25.1) 54 (13.6) 17 (19.3)
Time of reading medicine leaflet
(n=413, 75.1%)
● At the first time of receiving 335 (81.1) 113 (78.5) 222 (82.5) 0.577 278 (81.3) 57 (80.3) 0.941
● Read when having some questions 59 (14.3) 24 (16.6) 35 (13.0) 48 (14.0) 11 (15.5)
● Read when adverse symptom hap-
pens and others
19 (4.6) 7 (4.9) 12 (4.5) 16 (4.7) 3 (4.2)
Frequency of keeping medicine
leaflet (n=413, 75.1%)
● Always 144 (34.9) 64 (44.4) 80 (29.7) 0.008 118 (34.5) 26 (36.6) 0.509
● Sometimes 203 (49.1) 63 (43.8) 140 (52.1) 172 (50.3) 31 (43.7)
● Never 66 (16.0) 17 (11.8) 49 (18.2) 52 (15.2) 14 (19.7)
Feeling after reading medicine
leaflet (n=413, 75.1%)
● Worried 53 (12.8) 17 (11.8) 36 (13.4) 0.741 45 (13.2) 8 (11.3) 0.014
● More confident to use medicine 318 (77.0) 114 (79.2) 204 (75.8) 269 (78.6) 49 (69.0)
● Othersc 42 (10.2) 13 (9.0) 29 (10.8) 28 (8.2) 14 (19.7)
Notes: aPearson Chi-Square test was used to determine differences between groups; p<0.05 with Bonferroni correction (p<0.0015). bReason of never reading medicine
leaflet: Had received enough information from doctors (n=38), pharmacists (n=40), have other sources of information (n=9), information from package inserts is not reliable
(n=1). cNot confident to use medicine (n=6), not sure (n=25), hesitate to use medicines (n=1), indifferent (n=3), not identified (n=7). Bold numbers of p-value indicate
statistical significance at p<0.05.
Abbreviations: PILs, patient information leaflets; N, number of respondents.
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Respondents reported that medicine labels (54.8%),
and booklets (32.4%) were other common sources of writ-
ten medicine information, but many also used electronic
information sources which were websites (55.1%), televi-
sion (48.1%), and Facebook (38.0%) (Table 2).
The contents of PIs that respondents usually read were
indications (n=347, 84.2%), followed by generic name of
the medicines (n=303, 73.5%) and precautions (n=292,
70.9%) (Table 3).
Needs and Expectations of Written and
Electronic Medicine Information
More than half of the respondents (n=344, 62.5%) were not
aware of PILs.Websites, mobile applications, and television or
radio, were perceived to be the most needed sources of elec-
tronic medicine information. However, most respondents per-
ceived PILs would be useful (n=487, 88.5%) with a higher
proportion of those who had received PILs agreeing with this
compared to those who had not (p=0.001) (Table 4). About
half of the respondents (n=289, 52.5%) expected that PILs
should be provided at every time of receiving a medicine. The
majority of respondents (n=461, 83.8%) supported that pro-
duction of PILs should be promoted by the Food and Drug
Administration (FDA). Almost all respondents (n=527,
95.8%) also felt they needed advice from HPs and most
(n=383, 69.6%) agreed that their need for this would be
unchanged if PILs were available, but this was higher among
respondents who had received PILs than among those who
had not (81.3% versus 65.5%; p=0.001). The majority of
respondents (n=433, 78.7%) reported that they would most
likely read a PIL after receiving amedicine for the first time, as
opposed to when they had questions (n=69; 12.6%) or when
side effects occurred (n=48; 8.7%) and that they would read
online PILs if they were available (n=412, 74.9%) (Table 4).
Respondents considered indications of medicines as
the most important information to be included in PILs
(n=464, 84.4%), followed by generic name of the medi-
cines (n=427, 77.6%) and precautions (n=406, 73.8%)
(Table 3).
Attitudes Towards PILs
The overall mean attitude score was 38.87±4.68. Around a
third of respondents (n=186, 33.8%) had moderate attitude
(mean=33.53±2.12) and the remaining 364 (66.2%) respon-
dents had good attitude (mean=41.60±4.75). None of the
patients had a negative attitude toward PILs. Responses to
the ten attitude statements are shown in Table 5.
A large majority of respondents agreed that PILs would
help them use their medication more accurately and safely
(n=544, 98.9% and n=514, 93.4%, respectively). PILs
Table 2 Sources of Written and Electronic Medicine Information
That Respondents Had Ever Received or Searched
Sources of Information N (%)
Written medicine information (n=515)
● PIs 486 (94.4)
● Labels on the envelopes 282 (54.8)
● Booklets 167 (32.4)
● PILs 144 (28.0)
● Books 95 (18.4)
● Supplementary labels added by pharmacists 90 (17.5)
● Newspapers 90 (17.5)
Electronic medicine information (n=432)
● Websites 238 (55.1)
● Television 208 (48.1)
● Facebook 164 (38.0)
● Application 117 (27.1)
● Chat program 81 (18.8)
● QR code 34 (7.9)
● Othera 24 (5.6)
● Twitter 13 (3.0)
Note: aSearch engine such as Google (n=18), Youtube (n=5), not report (n=1).
Abbreviations: PIs, package inserts; PILs, patient information leaflets; N, number
of respondents.
Table 3 Content of PIs Usually Read and Content of PILs
Perceived as Necessary






Indications 347 (84.2) 464 (84.4)
Drug name 303 (73.5) 427 (77.6)
Precautions 292 (70.9) 406 (73.8)
Directions 288 (69.9) 350 (63.6)
Possible side effects 84 (20.4) 299 (54.5)
Contraindications 193 (46.8) 241 (43.8)
Active ingredients 102 (24.8) 136 (24.7)
Interactions with other drugs, food,
and herbs
217 (52.7) 103 (18.7)
What to do if side effects happen 101 (24.5) 109 (19.9)
What to do if you overdose 61 (14.8) 99 (18.0)
Storage 188 (45.6) 83 (15.1)
What to do if the dose is missed 83 (20.1) 76 (13.8)
What to do while you are taking
the drug
190 (46.1) –
Othersa 4 (1.0) –
Notes: aExpiry date (n=3), drug allergy (n=1).
Abbreviations: PIs, package inserts; PILs, patient information leaflets.
Dovepress Wongtaweepkij et al
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were considered as a source of information that could be
easily accessed (n=528, 96.0%). However, PILs would not
be their first choice of information source if they had
questions about medicines (n=324, 58.9%). Around a
third of respondents (n=177, 32.2%) agreed that reading
PILs would make them feel worried or lacking confidence
in using the medicine, and over half that they would still
need advice from HPs (n=299, 54.4%). A large majority
agreed that should be provided with all marketed medi-
cines (n=507, 92.2%). Conversely, over two-thirds of
respondents disagreed that reading PILs was a waste of
time (n=378, 68.7%). Most respondents agreed that online
medicine information should be provided as another
source of medicine information (n=454, 82.5%) and that
Table 4 Expectations of Medicine Information in Relation to Receiving PILs and Accessing Electronic Medicine Information
Expectation Total
(N=550)




















● Yes 206 (37.5) 144 (100.0) 62 (15.3) <0.001 180 (41.7) 26 (22.0) <0.001
● No 344 (62.5) 0 (0.0) 344 (84.7) 252 (58.3) 92 (78.0)
Perceived usefulness of PILs
● Useful 487 (88.5) 140 (97.2) 137 (85.5) 0.001 397 (91.9) 90 (76.3) <0.001
● Not useful 8 (1.5) 1 (0.7) 7 (1.7) 1 (0.2) 7 (5.9)
● Not sure 55 (10.0) 3 (2.1) 52 (12.8) 34 (7.9) 21 (17.8)
Time that PILs should be
provided
● With the first dose 261 (47.5) 79 (54.9) 182 (44.8) 0.038 195 (45.1) 66 (55.9) 0.037
● Every time receiving a medicine 289 (52.5) 65 (45.1) 224 (55.2) 237 (54.9) 52 (44.1)
FDA should support production
of PILs
● Yes 461 (83.8) 126 (87.5) 335 (82.5) 0.278 375 (86.8) 86 (72.9) 0.001
● No 10 (1.8) 1 (0.7) 9 (2.2) 6 (1.4) 4 (3.4)
● Not sure 79 (14.4) 17 (11.8) 62 (15.3) 51 (11.8) 28 (23.7)
Needs for HP’s advice
● Yes 527 (95.8) 142 (98.6) 385 (94.8) 0.051 419 (97.0) 108 (91.5) 0.016b
● No 23 (4.2) 2 (1.4) 21 (5.2) 13 (3.0) 10 (8.5)
Level of needs for HP’s advice
● Unchanged 383 (69.6) 117 (81.3) 266 (65.5) 0.001 315 (72.9) 68 (57.6) 0.001
● Decreased 86 (15.6) 18 (12.5) 68 (16.7) 66 (15.3) 20 (17.0)
● Not sure 81 (14.7) 9 (6.3) 72 (17.7) 51 (11.8) 30 (25.4)
Time to start reading PILs
● First time of receiving medicine 433 (78.7) 119 (82.6) 314 (77.3) 0.156 350 (81.0) 83 (70.3) 0.032
● When side effect occurs 48 (8.7) 7 (4.9) 41 (10.1) 32 (7.4) 16 (13.6)
● When having a question 69 (12.6) 18 (12.5) 51 (12.6) 50 (11.6) 19 (16.1)
Reading online PILs if they are
available
● Yes 412 (74.9) 118 (81.9) 294 (72.4) 0.016 346 (80.1) 66 (55.9) <0.001
● No 20 (3.6) 7 (4.9) 13 (3.2) 9 (2.1) 11 (9.3)
● Not sure 118 (21.5) 19 (13.2) 99 (24.4) 77 (17.8) 41 (34.8)
Notes: aPearson Chi-Square test was used to determine differences between groups; p<0.05 with Bonferroni correction (p<0.0015). bFisher’s Exact test. Bold numbers of
p-value indicate statistical significance at p<0.05.
Abbreviations: PILs, patient information leaflets; N, number of respondents; FDA, Food and Drug Administration.
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a QR code linked to an online PIL should be on medicine
packages (n=428, 77.8%) (Table 5).
Discussion
The results of our study showed that a high proportion of
the Thai general public have received some written med-
icine information, with PIs and medicine labels being the
most common sources. Most participants read the leaflets
inside medicine packages, which could be a PI or PIL,
but only just over a quarter had received a PIL with a
medicine. The findings are similar to those of a recent
outpatient survey in which 91% had received a PI but
only 24% had ever heard of PILs.18 This is most likely
due to the current situation in Thailand, where PILs are
not a legal requirement to accompany prescription med-
icines which constitute a large proportion of marketed
medicines.19 This situation differs from practices in
most high-income countries. For example in Australia,
provision of consumer medicine information is obliged
by the professional guideline produced by the
Pharmaceutical Society of Australia.26 And more than
80% Australian consumers reported they received written
information from pharmacists and inside the medicine
boxes.27 In the UK, provision of information specific to
patients with all medicines has been obliged by law since
199928 and 97% of patients were aware of having
received one in 2006.29
Self-reported reading of leaflets provided with medi-
cines shows considerable variation across studies; for
example, 91% claimed to read PILs in a survey in
Nigeria,30 while studies in Pakistan have reported that
between 23% and 61% never read PIs.31 More than half
of the respondents in our study (61%) claimed to always
read the leaflets they received and 81% if it was the first
time of use, which was slightly higher compared to the
UK, where 71% of first-time medicine users read the
PIL.29
The contents of PIs that our respondents usually read
were the same as those considered necessary sections in the
PILs, which were indication, drug name and precautions.
These differed from the findings of some other studies in
which side-effect section, dosage, when and how long to take
it were the most commonly read or identified as important
sections of medicine information leaflets.29,32,33 However,
there were similar findings in a survey from Sri Lanka,
where name, dose, indication and side effects were reported
Table 5 Attitudes of Respondents Towards PILs
Statements Attitudes (N, %) Mean ± S.D.
Absolutely
Agree
Agree Not Sure Disagree Absolutely
Disagree
1. The PILs will help you use your medication more accurately. 402 (73.1) 142 (25.8) 4 (0.7) 0 (0.0) 2 (0.4) 4.71 ± 0.513
2. The PILs make you use the medicines more safely. 312 (56.7) 202 (36.7) 28 (5.1) 3 (0.5) 5 (0.9) 4.48 ± 0.703
3. The PILs are the source of medicine information that is easily
access.
316 (57.5) 212 (38.5) 19 (3.5) 3 (0.5) 0 (0.0) 4.53 ± 0.593
4. The PILs are not the first choice after you have a question about
medicine.
136 (24.7) 188 (34.2) 101 (18.4) 88 (16.0) 37 (6.7) 3.54 ± 1.212
5. The PILs make you feel worried or unconfident to use the
medicine.
79 (14.4) 98 (17.8) 98 (17.8) 201 (36.5) 74 (13.5) 2.83 ± 1.277
6. You do not need for advice from healthcare professionals if the
PILs are available.
98 (17.8) 83 (15.1) 69 (12.5) 196 (35.6) 104 (18.9) 2.77 ± 1.389
7. The PILs should be provided in all marketed medicines. 317 (57.6) 190 (34.5) 34 (6.2) 7 (1.3) 2 (0.4) 4.48 ± 0.703
8. Reading the PILs is a waste of time for you. 61 (11.1) 72 (13.1) 39 (7.1) 250 (45.5) 128 (23.3) 2.43 ± 1.281
9. The online form of the PILs should be provided to patients in
order to easily access.
234 (42.5) 220 (40.0) 60 (10.9) 20 (3.6) 16 (2.9) 4.16 ± 0.959
10. The QR codes of the PILs should be attached with the medicine
packages in order to read online medicine information conveniently.
234 (42.5) 194 (35.3) 81 (14.7) 23 (4.2) 18 (3.3) 4.10 ± 1.013
Abbreviations: PILs, patient information leaflets; S.D., standard deviation; N, number of respondents.
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as the most desired sections in WMI.34 Indication was also
the most desired item of information in surveys in Nigeria30
and Ghana,35 hence it is clear that these preferences vary
across countries and may depend on information obtained by
other means, such as verbally from health professionals. The
safety information, such as side effects, precautions, contra-
indications, contained in PIs and PILs is particularly impor-
tant for reducing adverse events in Thailand, since previous
research has shown that patients rarely receive such informa-
tion from health professionals.36
Our study found that younger people, those with higher
educational levels and on higher incomes were more likely
to have read information provided with medicines. This is
in line with studies from high-income countries, where
higher educational level is strongly associated with read-
ing the package leaflets.37,38 Low-educated people or lack
of literacy influenced information-seeking behavior about
health issues.33 The healthcare insurance system in
Thailand means that most people who have low income
and lower education have less access to imported origina-
tor products where the PILs are mainly provided.17 Our
study also found that more people who were younger,
highly educated and receiving high-income have searched
for electronic information about medicines. Access to
computers at work could be one factor that could explain
the high proportion in these groups who have searched for
information on the internet.39 Studies elsewhere have also
found that younger people are more likely to use the
internet to search for both medical information generally
and medicine information, due to the speed and ease of
access it offers.15
A large majority of our respondents thought PILs would
be useful and would read them, although expectations of
PILs differed between those who had and had not experi-
enced PILs. Receiving PILs increased perceptions of useful-
ness and awareness of PILs. While 92% agreed that PILs
should be provided with all marketed medicines and 84%
that the FDA should promote their use, only 53% thought
they should be provided every time a medicine is dispensed,
which is similar to the views of Thai outpatients.18 Although
respondents who had received PILs were also more likely to
search for online medicine information, online medicine
information was viewed positively by over 80%, and 78%
also agreed that medicine packages should have a QR code
linked to an online PIL. Such findings are important for both
regulators and manufacturers.
Despite the desire expressed for WMI in both paper
and electronic form, it is clear that advice from the health
professionals would still be needed, if WMI was more
widely available. Although clearly viewed as easily acces-
sible sources of information, PILs would not be the first
choice of information source for people having questions
about their medicines. Thus, pharmacists and physicians
continue to have an important role providing both verbal
and written information to patients.27 Previous work in
Thailand has shown that a limited number of health pro-
fessionals currently provide WMI to outpatients during the
care process, despite viewing PILs as potentially useful.40
A study in Ghana found that if hospital pharmacists
encouraged patients to read the PIL, this resulted in higher
reading rates.41 Thus, if PILs were more widely available
in Thailand, as is clearly desired by patients, the public
and health professionals,36,40 advice to read it should also
be provided when prescribing or supplying medicines.
Concerns about the provision of medicine information
causing anxiety and reducing adherence have been
expressed, both among Thai health professionals and
elsewhere.42,43 This study showed that 32% of the popula-
tion felt they may be worried by receiving a PIL, which is
less than the 49% was found in an earlier study in Thai
outpatients.36
Implications for Practice and Policy
Greater provision of written information about medicines
needs to be supported by the Thai FDA in terms of both
quantity and quality, in a variety of formats. While this is
especially important for those starting a medicine for the
first time to make sure that consumers understand about
benefits and risks enabling shared decision-making, the
only way to assure this is for information to be available
with all medicines and online. While PIs are now wide-
spread in Thailand, PILs are seen as desirable by patients
and the public. Hence, as well as providing verbal infor-
mation, pharmacists and doctors should endeavor to pro-
vide PILs routinely and advise patients to read them.
Moreover, electronic medicine information should be
freely available on websites regarded as trustworthy to
enable easy and quick access.
Strengths and Limitations
Our study is the first survey of written medicine informa-
tion use and need involving the Thai general public and
their attitudes towards PILs. We made sure that partici-
pants in our study understood the difference between PIs
and PILs giving samples of both, since this was crucial to
the aim of the survey. However, we used convenience
Wongtaweepkij et al Dovepress
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sampling in only one area of northeast Thailand; hence,
the results might not be representative of other regions.
Furthermore, the views obtained in our study may differ
from those of the general public in other countries, where
provision of medicine information differs in terms of
practices and policies and there may be variable access
to electronic sources of information.
Conclusion
This study showed that the views of the general public in
Thailand towards the availability of written medicine
information concur with those previously found in out-
patients. Although most Thai people had received a PI
with a medicine, they considered PILs desirable and use-
ful, hence there is a need for more widespread availability
of the latter. Online medicine information is used by the
public and should also be further developed. Electronic
PILs which can be accessed via a QR code on medicine
packages would be a further useful development.
Disclosure
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References
1. Raynor DK, Savage I, Knapp P, Henley J. We are the experts: people
with asthma talk about their medicine information needs. Patient Educ
Couns. 2004;53(2):167–174. doi:10.1016/S0738-3991(03)00126-5
2. Al-Saffar N, Deshmukh AA, Carter P, Adib SM. Effect of information
leaflets and counselling on antidepressant adherence: open randomised
controlled trial in a psychiatric hospital in Kuwait. Int J Pharm Pract.
2005;13(2):123–132. doi:10.1211/0022357056181
3. Hamrosi K, Dickinson R, Knapp P, et al. It’s for your benefit: explor-
ing patients’ opinions about the inclusion of textual and numerical
benefit information in medicine leaflets. Int J Pharm Pract. 2013;21
(4):216–225. doi:10.1111/j.2042-7174.2012.00253.x
4. Schmitt MR, Miller MJ, Harrison DL, et al. Communicating non-
steroidal anti-inflammatory drug risks: verbal counseling, written med-
icine information, and patients’ risk awareness. Patient Educ Couns.
2011;83(3):391–397. doi:10.1016/j.pec.2010.10.032
5. Knapp P, Raynor DK, Berry DC. Comparison of two methods of
presenting risk information to patients about the side effects of med-
icines. Qual Saf Heal Care. 2004;13(3):176–180. doi:10.1136/qshc.
2003.009076
6. Maclennan K, Brounéus F, Parkin L. Public knowledge and desire for
knowledge about drug safety issues: a survey of the general public in
New Zealand. Pharmaceut Med. 2016;30:339–348.
7. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N.
Knowledge and perceptions of the risks of non-steroidal anti-
inflammatory drugs among orthopaedic patients in Thailand. Int J
Clin Pharm. 2016;38(5):1269–1276. doi:10.1007/s11096-016-
0363-9
8. Hamrosi KK, Raynor DK, Aslani P. Pharmacist and general practi-
tioner ambivalence about providing written medicine information to
patients – a qualitative study. Res Soc Adm Pharm. 2013;9(5):517–
530. doi:10.1016/j.sapharm.2013.02.006
9. Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J.
Experiences of and attitudes towards receiving information about
non-steroidal anti-inflammatory drugs: a cross-sectional survey of
patients in Thailand. Expert Opin Drug Saf. 2016;338:1–10.
10. Rajesh R, Vidyasagar S, Varma DM, Guddattu V, Hameed A.
Evaluating the impact of educational interventions on use of highly
active antiretroviral therapy and adherence behavior in Indian human
immunodeficiency virus positive patients: prospective randomized
controlled study. J AIDS Clin Res. 2013;4:231.
11. Akour A, Bardaweel S, Awwad O, Al-Muhaissen S, Hussein R.
Impact of a pharmacist-provided information booklet on knowledge
and attitudes towards oral contraception among Jordanian women: an
interventional study. Eur J Contracept Reprod Heal Care.
2017;22:459–464. doi:10.1080/13625187.2017.1412425
12. Mai A, Aslani P. Impact of Vietnamese written and verbal medicine
information on Vietnamese-speaking Australians‘ knowledge and
satisfaction. Br J Clin Pharmacol. 2007;64(4):527–535. doi:10.11
11/j.1365-2125.2007.02968.x
13. Morrow DG, Weiner M, Young J, Steinley D. Improving medication
knowledge among older adults with heart failure: a patient-centered
approach to instruction design. Gerontologist. 2005;45(4):545–552.
doi:10.1093/geront/45.4.545
14. Smith KG, Booth JL, Stewart D, Pfleger S, McIver L, Maclure K.
Supporting shared decision-making and people’s understanding of
medicines: an exploration of the acceptability and comprehensibility
of patient information. Pharm Pract (Granada). 2017;15:1–7.
15. Abanmy NO, Al-quait NA, Alami AH, Al-juhani MH, Al-aqeel S.
The utilization of Arabic online drug information among adults in
Saudi Arabia. Saudi Pharm J. 2012;20(4):317–321. doi:10.1016/j.
jsps.2012.07.001
16. Ciciriello S, Johnston RV, Osborne RH, et al. Multimedia educational
interventions for consumers about prescribed and over-the-counter
medications. Cochrane Database Syst Rev. 2013;30:CD008416.
17. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N. Medicine
information leaflets for non-steroidal anti-inflammatory drugs in
Thailand. Int J Clin Pharm. 2016;38(1):25–29. doi:10.1007/s11096-
015-0220-2
18. Pongpunna S, Pratipanawatr T, Jarernsiripornkul N. Survey of outpati-
ents’ use and needs of patient medicine information leaflets in Thailand.
Int J Clin Pharm. 2018;41:141–150. doi:10.1007/s11096-018-0748-z
19. Division of Innovative Health Products and Services, Food and Drug
Administration [homepage on the Internet]. Guideline for leaflet devel-
opment for drug research and innovation; 2019. Available from: www.
fda.moph.go.th/sites/oss/Shared%20Documents/SmPC-PIL_HPEP%
20guideline_updated%20May2019.pdf. Accessed March 25, 2020.
20. Liu F, Abdul-Hussain S, Mahboob S, Rai V, Kostrzewski A. How
useful are medication patient information leaflets to older adults? A
content, readability and layout analysis. Int J Clin Pharm. 2014;36
(4):827–834. doi:10.1007/s11096-014-9973-2
21. Al-Aqeel SA. Evaluation of medication package inserts in Saudi
Arabia. Drug Healthc Patient Saf. 2012;4(1):33–38. doi:10.2147/
DHPS.S29402
22. Ramdas D, Chakraborty A, Swaroop H, Faizan S, Praveen Kumar V,
Srinivas BN. A study of package inserts in Southern India. J Clin
Diagnostic Res. 2013;7(11):2475–2477.
23. Patsuree A, Krska J, Jarernsiripornkul N. Experiences relating to adverse
drug reactions in the community: a cross-sectional survey among patients
and the general public in Thailand. Expert Opin Drug Saf. 2016;338:1–9.
24. Samma K, Youngpattana W, Srinonghang S Experience of adverse
reaction and behavior of taking herbal medicines and dietary supplement
[Unpublished Report]. Khon Kaen: Khon Kaen University; 2017.
25. Phueanpinit P, Jarernsiripornkul N, Pongwecharak J, Krska J.
Hospital pharmacists’ roles and attitudes in providing information
on the safety of non-steroidal anti-inflammatory drugs in Thailand.
Int J Clin Pharm. 2014;36(6):1205–1212. doi:10.1007/s11096-014-
0018-7
Dovepress Wongtaweepkij et al

































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
26. Jay E, Aslani P, Raynor D. User testing of consumer medicine
information in Australia. Health Educ J. 2010;70:420–427.
doi:10.1177/0017896910376131
27. Hamrosi KK, Raynor DK, Aslani P. Pharmacist, general practitioner
and consumer use of written medicine information in Australia: are
they on the same page? Res Soc Adm Pharm. 2014;10(4):656–668.
doi:10.1016/j.sapharm.2013.10.002
28. The Medicines and Healthcare Products Regulatory Agency [home-
page on the Internet]. Best practice guidance on patient information




29. Raynor D, Silcock J, Knapp P, Edmondson H. How do patients use
medicine information leaflets in the UK? Int J Pharm Pract. 2007;15
(3):209–218. doi:10.1211/ijpp.15.3.0008
30. Afolabi MO, Akinwale VO, Akinyemi OA, Irinoye AI. Patient use
and perception of medicine information leaflets. Pharmacoepidemiol
Drug Saf. 2012;21:110.
31. Rahim N, Rafiq K, Iffat W, Nesar S, Shakeel S. Patients comprehen-
sion of pharmaceutical package inserts information in Karachi,
Pakistan. Trop J Pharm Res. 2015;14(12):2307–2311. doi:10.4314/
tjpr.v14i12.22
32. Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of
quantitative and qualitative research on the role and effectiveness of
written information available to patients about individual medicines.
Health Technol Assess. 2007;11(5):1–160. doi:10.3310/hta11050
33. Hamrosi KK, Aslani P, Raynor DK. Beyond needs and expectations:
identifying the barriers and facilitators to written medicine informa-
tion provision and use in Australia. Heal Expect. 2014;17:220–231.
doi:10.1111/j.1369-7625.2011.00753.x
34. Perera T, Ranasinghe P, Perera U, et al. Knowledge of prescribed
medication information among patients with limited English profi-
ciency in Sri Lanka. BMC Res Notes. 2012;5(1):658. doi:10.1186/
1756-0500-5-658
35. Kyei S. Patients’ information leaflets: its’ influence on ophthalmic
patient education and medication compliance. Br J Med Med Res.
2014;4(5):1217–1230. doi:10.9734/BJMMR/2014/6383
36. Jarernsiripornkul N, Phueanpinit P, Pongwecharak J, Krska J.
Experiences of and attitudes towards receiving information about
non-steroidal anti-inflammatory drugs: a cross-sectional survey of
patients in Thailand. Expert Opin Drug Saf. 2016;15:417–426.
doi:10.1517/14740338.2016.1139571
37. Koo MM, Krass I, Aslani P, Guzmàn WM, Le Duff M. Factors influen-
cing consumer use of written drug information. Ann Pharmacother.
2003;37(2):259–267. doi:10.1177/106002800303700218
38. Vinker S, Eliyahu V, Yaphe J. The effect of drug information leaflets
on patient behavior. Isr Med Assoc J. 2007;9(5):383–386.
39. Nangsangna RD, Da-costa Vroom F. Factors influencing online health
information seeking behavior among patients in Kwahu West Municipal,
Nkawkaw, Ghana. Online J Public Health Inform. 2019;11(2):e13.
40. Jarernsiripornkul N, Nakboon S, Anarj K, Wongtaweepkij K. Survey
of healthcare professionals’ practices, expectations, and attitudes
towards provision of patient information leaflets in Thailand. Int J
Clin Pharm. 2020;42(2):539–548. doi:10.1007/s11096-020-00965-x
41. Ankrah DNA, Ofei CN. The effect of advice to read the medicine/
patient information leaflet among patients in Ghana: a cross-sectional
study. J Pharm Heal Serv Res. 2010;1:91–96. doi:10.1111/j.1759-
8893.2010.00009.x
42. Phueanpinit P, Pongwecharak J, Krska J, Jarernsiripornkul N.
Evaluation of community pharmacists’ roles in screening and com-
munication of risks about non-steroidal anti-inflammatory drugs in
Thailand. Prim Heal Care Res Dev. 2018;19:598–604. doi:10.1017/
S1463423618000142
43. Phueanpinit P, Pongwecharak J, Sumanont S, Krska J,
Jarernsiripornkul N. Physicians’ communication of risks from non-
steroidal anti-inflammatory drugs and attitude towards providing
adverse drug reaction information to patients. J Eval Clin Pract.
2017;23(6):1387–1394. doi:10.1111/jep.12806
Patient Preference and Adherence Dovepress
Publish your work in this journal
Patient Preference and Adherence is an international, peer-reviewed,
open access journal that focusing on the growing importance of
patient preference and adherence throughout the therapeutic conti-
nuum. Patient satisfaction, acceptability, quality of life, compliance,
persistence and their role in developing new therapeutic modalities
and compounds to optimize clinical outcomes for existing disease
states are major areas of interest for the journal. This journal has
been accepted for indexing on PubMed Central. The manuscript
management system is completely online and includes a very quick
and fair peer-review system, which is all easy to use. Visit http://
www.dovepress.com/testimonials.php to read real quotes from pub-
lished authors.
Submit your manuscript here: https://www.dovepress.com/patient-preference-and-adherence-journal
Wongtaweepkij et al Dovepress
submit your manuscript | www.dovepress.com
DovePress































































Powered by TCPDF (www.tcpdf.org)
                               1 / 1
